This video is 35 minutes long and is very much worth reviewing.
Video | ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD: Key Points from the 2019 ACC Task Force on Expert on Expert Consensus Decision Pathways
Feb 21, 2019 | Brendan Everett, MD, FACC ; James L. Januzzi, Jr., MD, FACC:
ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD: Key Points from the 2019 ACC Task Force on Expert on Expert Consensus Decision Pathways | Drs. Brendan Everett and James Januzzi discuss the key points from the Expert Consensus Document on “Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.”
And remember that if you watch the video on YouTube you can follow along with the auto-generated transcript.
To access the YouTube auto-generated transcript, go to the far right on line below the title line and click on the three dots [“. . .”]. That will open a menu and you will click on “transcript”.
And I’ve embedded the above video in this post:
ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD
From The American College of Cardiology
Note to myself: In addition to the resource above, please review:
- Link To And Excerpts From The Vidcast And Transcript To “ACC Pathway Empowers Cardiologists to Use Diabetes Drugs for Heart Disease” From Medscape. Posted on November 1, 2019 by Tom Wade MD
- Link To And Excerpts From The Article ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD. Posted on November 2, 2019 by Tom Wade MD
- Link To “Video | ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD: Key Points from the 2019 ACC Task Force on Expert on Expert Consensus Decision Pathways”. Posted on November 2, 2019 by Tom Wade MD
- Links To And Excerpts From “2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease”. Posted on November 2, 2019 by Tom Wade MD
